Background: A role for sex hormone-binding globulin (SHBG) in determining the pregnancy outcome was evidenced by the rise in SHBG levels during pregnancy linked with favorable pregnancy, while reduction in SHBG levels and hyperandrogenemia were linked with poor pregnancy outcome. Since SHBG production is genetically determined, this study investigated the association of SHBG polymorphisms with the susceptibility to recurrent pregnancy loss (RPL). Methods: Retrospective case-control study, involving 308 women with RPL, and 310 control women RPL, defined as ≥3 consecutive miscarriages, and with the same partner, was the main outcome measure. SHBG genotyping was done by allelic exclusion method (real-time PCR).
Background
Recurrent pregnancy loss (RPL), defined as two or more clinically failed pregnancies, is a significant pregnancy complication which affects 2-3% of otherwise healthy women, with poor etiology [1] [2] [3] . RPL is associated with metabolic and hormonal disorders, including hyperprolactinemia [3, 4] , hypothyroidism [4, 5] , hyperinsulinemia and hyperandrogenemia [2, 3, 6] . Hormonal imbalances, particularly during early stages of pregnancy, were linked with RPL, as inadequate progesterone levels in early pregnancy was linked with termination of pregnancy [1, 7] , and as elevated FSH/LH in early pregnancy were linked with pregnancy complications, including RPL [2, 8] .
Several studies documented the association of hyperandrogenemia with RPL [2, 9] , often with inconclusive findings. This was attributed to the wide variation in androgen levels, the time of sampling (i.e. within 7 days of the cycle), and the testosterone pool examined. The latter was attributed to the lipophilic nature of steroid sex hormones, in which circulating androgens and estrogens bind albumin and sex hormone binding globulin (SHBG), resulting in limited amounts of non-bound sex hormones, and hence reduced bioavailability [9, 10] . Accurate assessment of biochemical hyperandrogenemia requires measurement of either free testosterone, or free androgen index, which require determination of the serum levels SHBG, a 373-amino acid glycoprotein produced mainly by the liver, and binding the testosterone, dihydrotestosterone, and estradiol [11, 12] , thus limiting their target tissue availability [12] .
A role for SHBG in determining the pregnancy outcome was suggested. A rise in SHBG levels during pregnancy was proposed as protective for the fetus and mother from excessive androgen exposure [13] , and reduction in SHBG levels and thus hyperandrogenemia were linked with pregnancy complications [11, 14] . SHBG gene is located on the short arm of chromosome 17 (17p13-17p12) [15] , and several genetic variants in SHBG gene were identified, and were associated with varied levels of SHBG [16, 17] , and with altered risk of RPL [18] .
We hypothesize that genetic variants in SHBG gene associated with reduced SHBG expression, induce hyperandrogenemia, and hence increased risk of RPL. We tested this notion by examining the association of common SHBG gene variants among women with confirmed RPL diagnosis, and age-and ethnically-matched control women. This is the first study to examine this association in a Middle Eastern population.
Methods

Study subjects
This retrospective case-control study was performed at outpatient OB/GYN clinics in Manama, and Rifaa (Bahrain). Study subjects comprised 308 consecutivelyrecruited women with confirmed RPL (mean age 31.6 ± 5.4 years), and 310 age-matched control women. RPL diagnosis was based on Royal College of Obstetricians and Gynecologists guidelines (www.rcog.org.uk/guidelines), which were consistent with American College of Obstetricians and Gynecologists guidelines. These included screening of anti-phospholipid antibodies (lupus anticoagulant and anti-cardiolipin antibodies), karyotyping of both partners, pelvic ultrasound scan for evaluation of uterine anatomy, and screening of inherited thrombophilia (Factor V-Leiden, prothrombin/factor II G20210A).
These procedures were performed on all women with RPL. The inclusion criteria were three or more idiopathic (unknown etiology) miscarriages, which occurred during the 1st trimester of gestation with the same partner. Exclusion criteria were 40 years or older at first pregnancy, incompatibility in Rh blood groups, history of preeclampsia, which was defined as rise in systolic and diastolic blood pressure (BP) above 145/95 mmHg, and/or elevation in systolic/diastolic BP above 30/15 mmHg on two or more occasions, biochemical pregnancy and/or preclinical miscarriages. In addition, systemic autoimmunity, diabetes, and thyroid dysfunction, anatomical disorders, infections, and liver function abnormalities constituted added exclusion criteria. Due to personal, cultural and religious concerns, karyotyping of the products of conception was not routinely done.
Controls consisted of 310 multiparous women, with two or more full-term live pregnancies, no miscarriages (spontaneous or induced), and negative family history of miscarriages. Control women comprised ethnically-matched hospital and university students and employees, and volunteers from the community, and were recruited after a routine check-up after uncomplicated pregnancies. All participants had normo-ovulatory cycles, and none had evidence of polycystic ovary syndrome. Research and Ethics Committee of the Arabian Gulf University approved the study protocol, which was done in accordance with the Helsinki Declaration principle; all participants were asked to sign a consent form prior to inclusion in the study.
SHBG genotyping
Blood samples were taken from all participants in EDTA-containing tube for total genomic DNA extraction, which was done by the Qiagen minispin column method, according to the instructions of the manufacturer (Qiagen, Hilden, Germany). We selected polymorphisms in SHBG gene with a minor allele frequency (MAF) of > 5% in Caucasians, using SNPbrowser software (version 4.0, Applied Biosystems, Foster City, CA, USA). Genotyping was performed in 6-μl volume by the allelic discrimination method on StepOne Plus real-time PCR system, according to manufacturer's instructions (Applied Biosystems). Assay-on-demand TaqMan primer pairs for the following SNPs: rs9898876, rs13894, rs858521, rs1799941, rs6257, rs6259, and rs727428 were ordered from Applied Biosystems. A typical genotyping reaction consisted of 2.2 μl DNA template added to 4. 0 μl TaqMan genotype master mix (TaqMan 2X mix, 1. 875 μl nuclease free water, and 0.125 μl 40X SNP primer mix) (Applied Biosystem). Pre-PCR (hold step; 30 s at 60°C and 10 min at 95°C) stage was followed by 35 cycles of denaturation (92°C for 15 s), annealing and extension (60°C for 1 min), followed by post-PCR stage at 60°C for 30 s. Replicate blinded quality control samples were included to assess reproducibility of the genotyping procedure; concordance was > 99%.
Statistical analysis
Statistical analysis was performed on SPSS version 24.0 (IBM, Armonk, NY). Continuous variables were expressed as mean ±SD, while categorical data were represented as frequency (percentage of total). Student's t-test was used to determine differences in means, and Pearson χ 2 or Fisher's exact test was used to assess inter-group significance. Genotypes were tested for departures from HardyWeinberg equilibrium (HWE) using Haploview version 4.2 (www.broad.mit.edu/mpg/haploview). All analyses were conducted under additive genetic effect, using SNPStats software (www.bioinfo.iconcologia.net/snpstats/). CaTS Power Calculator (www.sph.umich.edu/csg/abecasis/cats) was used in calculating the power for detecting an association between SHBG variants and RPL. The parameters used were 308 RPL cases and 310 control women, genotypic relative risk for heterozygous and minor allele homozygous, and MAF of the tested SNPs for RPL cases and controls, and assuming a 2.5% RPL prevalence rate (unpublished Bahrain Ministry of Health statistics). Assuming these parameters, the overall power (81.0%) was calculated as the average power of the seven tested SNPs. Linkage disequilibrium (LD) analysis was performed using Haploview 4.2, and haplotype reconstruction was performed by the expectation maximization method (Haploview 4.2). Logistic regression analysis was used to examine the association between SHBG SNP and RPL, presented as odds ratio (OR) with 95% confidence intervals (CI), after controlling for the following potential confounders: BMI, systolic and diastolic blood pressure, number of pregnancies, and age at menarche; statistical significance being set at P < 0.05.
Results
Demographic and clinical characteristics of RPL cases and control women
The demographic and clinical characteristics of RPL cases and control women are shown in Table 1 . Mean age at entry of study, serum glucose, gravida, and prevalence of smoking were comparable between cases and controls. Mean BMI (P = 0.004), menarche (P < 0.001), and systolic and diastolic blood pressure (P < 0.001) were different between RPL cases and control women. These were the main covariates selected that were controlled for in subsequent analysis.
Association between SHBG SNP and the risk of RPL
Genotype distributions of the tested SHBG variants were in Hardy-Weinberg equilibrium among study subjects Table 2 . summarizes the association between SHBG SNP and RPL in cases and control subjects. At the allele level, lower MAF of rs6257 (P = 0.001) was seen in RPL cases than in control women, which translated into lower risk of RPL, after controlling for BMI, menarche, systolic and diastolic blood pressure [aOR (95% CI) = 0.59 (0.43-0.81)]. MAF of the remaining SHBG SNPs were not significantly different between RPL cases and control women.
The distribution of SHBG genotypes between RPL cases and control women are shown in Table 3 . Significantly higher frequencies of heterozygous rs858521 (0. 51 vs. 0.44) and rs6259 (0.07 vs. 0.03), and homozygous rs858521 (0.28 vs. 0.26) genotype carriers, and reduced frequency of heterozygous rs6257 (0.23 vs. 0.32) and homozygous rs6257 (0.05 vs. 0.08) and rs6259 (0.003 vs 0.03) genotype carriers were seen in RPL cases vs. control women, respectively. The distribution of the remaining genotypes was comparable between RPL cases and control women. Table 3) .
Identification of SHBG haplotypes associated with RPL
We evaluated the interaction between the six tested SHBGSNPs and their mode of inheritance in RPL cases and control women. The SHBG SNPs were aligned according to their chromosomal locations (www.ncbi.nlm. nih.gov/snp), and the interaction between any all possible pair of SNPs was visualized by Haploview ( Fig. 1) . Haploview analysis demonstrated marked LD among SHBG SNPs (Fig. 1) . Each haplotype contains the next six loci: rs13894-rs858521-rs1799941-rs6257-rs6259-rs727428 and only 12 haplotypes were captured. Of the theoretical 64 haplotypes, only 12 were found to be common, capturing 91.8% of all haplotype pool, and were included in subsequent analysis. Within these haplotypes, only increased frequency of CCGTGA (P = 6.5 × 10
) haplotypes was seen in RPL cases, thus conferring disease susceptibility (OR = 1.66 (1.16-2.38) ( Table 5 ).
Discussion
Overview of the association of SHBG SNPs with RPL
Mounting evidence suggests that hyperandrogenemia in RPL is associated with abnormal LH levels and altered sex hormone production by ovaries or adrenal glands [2, 9] , increased peripheral aromatase activity, or decreased testosterone clearance [19, 20] . Since SHBG is key to hyperandrogenemia, and as SHBG production is genetically determined [17] , we investigated the association of SHBG variants with RPL. SHBG gene is highly polymorphic, and 
Significance of the findings
While many SHBG gene variants were reported, the novel finding here was the strong association of three of the seven tested variants (rs6257, rs6259, rs858521) with RPL. Compared to previous studies, this study is distinct in the relatively large sample size, new SHBG variants investigated, and the population investigated. This extends the list of SHBG gene variants implicated in RPL pathogenesis, thereby supporting a key role for SHBG in RPL, presumably through controlling hyperandrogenemia.
Main findings
The main finding here was the strong association of rs6257 with reduced risk of RPL at the allele level, while both rs858521 and rs6259 were positively associated with RPL at the genotype level. Of these, only heterozygous rs6259 remained associated with RPL after controlling for mean BMI, menarche, and blood pressure, since RPL cases were not matched to controls. Six-locus (rs13894-rs858521-rs1799941-rs6257-rs6259-rs727428) SHBG haplotype identified CCGTGA haplotype to be positively associated with increased risk of RPL. Significant differences were noted with respect to mean BMI, menarche, and systolic and diastolic blood pressure readings were different between RPL cases and control women. Although they did not constitute strong risk factors of RPL, they were selected as the covariates that were controlled for in subsequent analysis. MAF of the tested SHBG variants among control women reflect the ethnic diversity of present-day Tunisians, which results from admixture of the ethnicities who sequentially invaded and populated Tunisia throughout history [21] . MAF of rs858521, rs1799941, and rs727428 was comparable between Bahraini and Caucasians (HapMap-CEU), and Africans. On the other hand, MAF of rs13894 and rs6257 were the highest recorded for any ethnic group, while MAF of rs6259 (0. 039) was intermediate between those recorded for Caucasians (0.124) and Africans (0.009). Furthermore, MAF of rs9898876 recorded for Bahraini (0.089) was lower than that established for Caucasians (0.222) and Africans (0.132). This underscores the need for evaluation Genotypes were coded as per "1" = major allele, "2" = minor allele c aOR = adjusted odds ratios; BMI and age were the main covariates that were controlled for 
Interpretation of results
Progressive increases in maternal SHBG levels are seen throughout pregnancy, ranging from 1.61% in first trimester to almost 6% during mid-to-late pregnancy [6, 11, 22] , which were suggested to protect mothers from androgen derived from the fetus [6, 23] . In contrast, minimal fluctuations in total testosterone (1.21-2.15%) and free testosterone (3.02-4.30%) levels were noted during pregnancy, suggesting that additional mechanisms operate in minimizing pregnancy-induced hyperandrogenemia [22, 23] . A role for SHBG in maintaining pregnancy was highlighted by the findings that reduction in SHBG levels were seen in miscarrying women compared to controls [14] . Insofar as genetic factors contribute to variation in SHBG levels, and thus and thus to the pathogenesis of gynecological diseases, low plasma SHBG levels, resulting from genetic variations in SHBG gene were associated with pregnancy complications, including RPL [24] . In this context, the present study evaluated the implication of seven SNPs in SHBG on RPL. Based on its allele and genotypes distribution in RPL cases and controls, our results suggest that SHBG rs6257 (Intron 1) gene variant may modulate the risk of RPL. While this variant was previously associated with OB/ GYN complications [25, 26] including PCOS [16, 27] , this is the first report to document its association with RPL. Despite its intronic location, rs6257 appears to have functional capacity, as it maps to a potential binding site for Hepatocyte Nuclear Factor 3/Fox transcription factor, which was shown to influence SHBG levels [28] . While not tested here, carriage of rs6257 minor allele alters testosterone binding to SHBG, and hence testosterone bioavailability and action at target tissue site, including reproductive organs and tissues [29] .
On the other hand, both rs6259 (D327N) and rs858521 were positively associated with RPL. While SHBG rs6259 is the most investigated of all reported SHBG variants, this is the first report describing its association with RPL. Mixed association of this variant with obstetric complications. For example, rs6259 was not associated with PCOS in Bahraini [16] , Turkish [30] , and Spanish [27] subjects. Moreover, this polymorphism was also studied in hormone-sensitive cancers and the results revealed that rs6259 minor allele was associated with reduced risk of endometrial cancer in postmenopausal, but not premenopausal women [31] . Reduced frequency of rs6259 minor allele was also reported in ovarian cancer [32] , and breast cancer [33] , presumably by increasing serum SHBG levels, particularly among postmenopausal women. Asn327 allele was associated with increased circulating SHBG levels, and with reduced estradiol-to-SHBG ratio, suggesting that rs6259 contributes the bioavailability of estrogens [34] . The functionality of D327N resides in the capacity of the (minor) Asn327 allele to decreases clearance rate of SHBG, resulting in increased half-life of SHBG and hence increased circulating SHBG levels [35] .
Study strengths and shortcomings
Our study has strengths. RPL cases and control women were ethnically matched, hence minimizing the problems of differences in genetic background inherent in genetic association studies. It was also sufficiently powered, and key covariates were controlled for in single SHBG variant and haplotype analysis. However, our Underlined indicates minor allele study had several limitations. We did not measure circulating SHBG levels, and thus could not address the cause-effect relationship, as well as determine free testosterone levels and free androgen index (hallmarks of hyperandrogenemia). Furthermore, matching for ethnic origin was dependent on self-declared Arab vs. NonArab Tunisian origin, thus prompting the speculation of genetic population stratification bias. Lastly, the study examined the association of RPL with seven common SHBG gene variants distributed between intronic, exonic, and 5′ and 3′ untranslated regions, thus questioning of the potential association of other (untested) SHBG variants with RPL.
Conclusion
In conclusion, this is the first study that demonstrated that SHBG rs858521 and rs6259, and to a lesser extent rs6257 variants, are associated with RPL. As mounting evidence suggest that some SHBG genetic variants influence SHBG levels, the mechanism by which SHBG influence the risk of RPL will expand on the role of SHBG in infertility. Follow up studies on additional SHBG variants, and populations of related and distant ethnic origin are needed to fully elucidate the association of altered SHBG production stemming from the presence of specific SHBG variants, and consequently hyperandrogenemia with the risk of RPL. 
